A Novel Coronavirus from Patients with Pneumonia in China, 2019
Новый коронавирус у пациентов с пневмонией в Китае, 2019 год
2020-01-24
SCID: 54.1/dpp7th65
Discuss with AI
2019-nCoVhuman airway epithelial cellsnovel betacoronavirussarbecovirusunbiased sequencing
Figures from the paper
Abstract (AI)
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.).
Key Findings
1
2019-nCoV was identified as the seventh coronavirus known to infect humans and was distinct from both MERS-CoV and SARS-CoV.
2
A previously unknown betacoronavirus was identified in patients with pneumonia of unknown cause in Wuhan, China, in December 2019.
3
Phylogenetic analysis placed 2019-nCoV within the sarbecovirus subgenus of the Orthocoronavirinae subfamily.
4
The virus was isolated using human airway epithelial cells, providing direct evidence of its ability to infect human respiratory tissue.
5
Unbiased sequencing of patient samples enabled discovery of the novel coronavirus, which was named 2019-nCoV.
Research Object
The novel human betacoronavirus 2019-nCoV isolated from patients with pneumonia in Wuhan, China
Research Subject
The virus’s genomic and phylogenetic characteristics, taxonomic classification, and ability to infect human airway epithelial cells
Publication Details
Publication Date
2020-01-24
Journal
Publisher
ISSN
Cited by
28818
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by20
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-192020
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status2020
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review2020
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study2020
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods2020
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine2020
A qualitative study on the psychological experience of caregivers of COVID-19 patients2020
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia2020
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-192020
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)2020
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐192020
Pandemics Throughout History2021
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series2020
SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup2020
Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-22020
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease2020